Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication
Artículo científico (JournalArticle)
Megalencephalic leukoencephalopathy with subcortical cysts: a personal biochemical retrospective
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by dysfunction of the role of glial cells in controlling brain fluid and ion homeostasis. Patients affected
by MLC present macrocephaly, cysts and white matter vacuolation, which lead to motor and cognitive impairments. To date, there is no treatment for MLC, only supportive care. MLC is caused by mutations in the MLC1
and GLIALCAM genes. MLC1 is a membrane protein with low identity to the Kv1.1 potassium channel and
GlialCAM belongs to an adhesion molecule family. Both proteins form a complex with an as-yet-unknown
function that is expressed mainly in the astrocytes surrounding the blood-brain barrier and in Bergmann glia.
GlialCAM also acts as an auxiliary subunit of the chloride channel ClC-2, thus regulating its localization at
cell-cell junctions and modifying its functional properties by affecting the common gate of ClC-2. Recent studies
in Mlc1-, GlialCAM- and Clcn2-knockout mice or Mlc1-knockout zebrafish have provided fresh insight into the
pathophysiology of MLC and further details about the molecular interactions between these three proteins.
Additional studies have shown that GlialCAM/MLC1 also regulates other ion channels (TRPV4, VRAC) or
transporters (Na+/K+-ATPase) in a not-understood manner. Furthermore, it has been shown that GlialCAM/
MLC1 may influence signal transduction mechanisms, thereby affecting other proteins not related with transport
such as the EGF receptor. Here, we offer a personal biochemical retrospective of the work that has been performed to gain knowledge of the pathophysiology of MLC, and we discuss future strategies that may be used to
identify therapeutic solutions for MLC patients., This work was supported in part by grants from the European Leukodystrophies Association (ELA) Research Foundation (ELA2012- 014C2B) to RE and VN, Ministerio de Ciencia e Innovación (SAF2012-31486 to RE and SAF2015-70377 to RE and ABG), Generalitat de Catalunya ((SGR2014-1178) to RE), (SGR2014-541) to VN)), Instituto de Salud Carlos III (bodies linked to MICINN and FEDER): (ERARE) to RE, FIS PI13/00121 to VN.